What is the address of Dr. Florence Van Ryckeghem, oncologie?

The registered office of Dr. Florence Van Ryckeghem, oncologie is located at Eendrachtstraat 77 box 101, 9000 Gent.

Is Dr. Florence Van Ryckeghem, oncologie still active?

Yes. According to the CBE (2 November 2026) Dr. Florence Van Ryckeghem, oncologie is active, legal situation “Normale toestand”, started on 6 October 2020.

Is Dr. Florence Van Ryckeghem, oncologie registered on Peppol?

No, Dr. Florence Van Ryckeghem, oncologie is currently not registered on the Peppol network.

What is the enterprise number of Dr. Florence Van Ryckeghem, oncologie?

The enterprise number of Dr. Florence Van Ryckeghem, oncologie is BE0755736205.

When was Dr. Florence Van Ryckeghem, oncologie founded?

Dr. Florence Van Ryckeghem, oncologie was founded on 6 October 2020.

Who are the directors of Dr. Florence Van Ryckeghem, oncologie?

According to the 2025 annual accounts, the directors of Dr. Florence Van Ryckeghem, oncologie are: Florence Van Ryckeghem.

Is Dr. Florence Van Ryckeghem, oncologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 October 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did Dr. Florence Van Ryckeghem, oncologie make in 2025?

Dr. Florence Van Ryckeghem, oncologie posted a profit after taxes of € 131,260 in financial year 2025.

What is the revenue of Dr. Florence Van Ryckeghem, oncologie?

As a small company, Dr. Florence Van Ryckeghem, oncologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 183,529.

Dr. Florence Van Ryckeghem, oncologie (Private Limited)

Dossier Dr. Florence Van Ryckeghem, oncologie, printed on 2 November 2026 from databakkes.be/en/0755736205/dr-florence-van-ryckeghem-oncologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr. Florence Van Ryckeghem, oncologie from Gent, company number BE0755736205, closed financial year 2025 with a result of € 131,260 after tax. For that financial year Dr. Florence Van Ryckeghem, oncologie recorded a gross margin of € 183,529 and equity of € 58,895. Compared with financial year 2024, the result moved from € 98,485 to € 131,260. Profitable, and profit is growing. The buffer shrank hard: equity is 86 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 1, 2026.

What it is worth Shrank hard

€ 58,895

▼ 86% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 131,260

▲ 33% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 125,630

▼ 63% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 490,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 3,263

▼ 77% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 146

▲ € 136 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,129

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 132,936 Gross margin 2022: € 132,936 First fiscal year in the series	€ 117,833 Gross margin 2023: € 117,833 ▼ 11% vs 2022 (€ 132,936) Unfavourable step	€ 134,226 Gross margin 2024: € 134,226 ▲ 14% vs 2023 (€ 117,833) Favourable step	€ 183,529 Gross margin 2025: € 183,529 ▲ 37% vs 2024 (€ 134,226) Favourable step	▲ 37%
Profit after taxes	€ 94,634 Profit after taxes 2022: € 94,634 First fiscal year in the series	€ 80,533 Profit after taxes 2023: € 80,533 ▼ 15% vs 2022 (€ 94,634) Unfavourable step	€ 98,485 Profit after taxes 2024: € 98,485 ▲ 22% vs 2023 (€ 80,533) Favourable step	€ 131,260 Profit after taxes 2025: € 131,260 ▲ 33% vs 2024 (€ 98,485) Favourable step	▲ 33%
Equity	€ 238,616 Equity 2022: € 238,616 First fiscal year in the series	€ 319,150 Equity 2023: € 319,150 ▲ 34% vs 2022 (€ 238,616) Favourable step	€ 417,635 Equity 2024: € 417,635 ▲ 31% vs 2023 (€ 319,150) Favourable step	€ 58,895 Equity 2025: € 58,895 ▼ 86% vs 2024 (€ 417,635) Unfavourable step	▼ 86%
Total debts	€ 38,440 Total debts 2022: € 38,440 First fiscal year in the series	€ 24,157 Total debts 2023: € 24,157 ▼ 37% vs 2022 (€ 38,440) Favourable step	€ 6,673 Total debts 2024: € 6,673 ▼ 72% vs 2023 (€ 24,157) Favourable step	€ 107,388 Total debts 2025: € 107,388 ▲ € 100,715 vs 2024 (€ 6,673) Unfavourable step	▲ € 100,715
Cash	€ 205,578 Cash 2022: € 205,578 First fiscal year in the series	€ 66,809 Cash 2023: € 66,809 ▼ 68% vs 2022 (€ 205,578) Unfavourable step	€ 342,926 Cash 2024: € 342,926 ▲ € 276,117 vs 2023 (€ 66,809) Favourable step	€ 125,630 Cash 2025: € 125,630 ▼ 63% vs 2024 (€ 342,926) Unfavourable step	▼ 63%
Retained profit	€ 228,616 Retained profit 2022: € 228,616 First fiscal year in the series	€ 309,150 Retained profit 2023: € 309,150 ▲ 35% vs 2022 (€ 228,616) Favourable step	€ 407,635 Retained profit 2024: € 407,635 ▲ 32% vs 2023 (€ 309,150) Favourable step	€ 48,895 Retained profit 2025: € 48,895 ▼ 88% vs 2024 (€ 407,635) Unfavourable step	▼ 88%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 490,000 Dividend 2025: € 490,000 Unchanged (€ 0) Unchanged
Bank debt	€ 25,470 Bank debt 2022: € 25,470 First fiscal year in the series	€ 14,200 Bank debt 2023: € 14,200 ▼ 44% vs 2022 (€ 25,470) Favourable step	€ 2,850 Bank debt 2024: € 2,850 ▼ 80% vs 2023 (€ 14,200) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 2,850) Favourable step	▼ 100%
Balance sheet total	€ 277,057 Balance sheet total 2022: € 277,057 First fiscal year in the series	€ 343,307 Balance sheet total 2023: € 343,307 ▲ 24% vs 2022 (€ 277,057) Unchanged	€ 424,308 Balance sheet total 2024: € 424,308 ▲ 24% vs 2023 (€ 343,307) Unchanged	€ 166,283 Balance sheet total 2025: € 166,283 ▼ 61% vs 2024 (€ 424,308) Unchanged	▼ 61%

Key figures of Dr. Florence Van Ryckeghem, oncologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Florence Van Ryckeghem, oncologie?

What happened at Dr. Florence Van Ryckeghem, oncologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 1, 2026 New annual accounts for financial year 2025: profit of € 131,260 (▲ 33% vs 2024). Source: NBB ↗
Oct 8, 2020 Incorporation, published in the Gazette. Source: Staatsblad ↗
Oct 6, 2020 New establishment in Ronse. KBO

In short

From € 94,634 profit in 2022 to € 131,260 profit in 2025.

Paid € 111,538 in corporate taxes since 2022.

Best year ever: 2025, with € 131,260 profit.

Paid out € 490,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Florence Van Ryckeghem

Dr. Florence Van Ryckeghem, oncologie

Behind Dr. Florence Van Ryckeghem, oncologie is Florence Van Ryckeghem.

Directors

According to the 2025 annual accounts

Florence Van Ryckeghem

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Eendrachtstraat 77 box 101

9000 Gent

2.309.095.292

Stefaan Modest Glorieuxlaan 55

9600 Ronse

Active since 6 October 2020

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Olaf's Brocante

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

8 October 2020 Source: Deed ↗

Florence Annie Pauline Van Ryckeghem(oprichter) 100%

Details

Company number: 0755.736.205
VAT number: BE 0755.736.205
Registered office: Eendrachtstraat 77 bus 101, 9000 Gent
Names & denominations: Dr. Florence Van Ryckeghem, oncologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 October 2020
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗